SALT LAKE CITY, Nov. 4, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the Lazard Capital Markets 7th Annual Healthcare Conference, at 3:10 p.m. Eastern on November 16, 2010, at the St. Regis Hotel in New York City and the Stephens Fall Investment Conference, at 9:30 a.m. Eastern on November 17, 2010, at the New York Palace Hotel in New York City.
